Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: J Pain. 2022 Sep 28;24(2):282–303. doi: 10.1016/j.jpain.2022.09.014

Table 6:

Baseline characteristics examined: hypothesized (●) moderators and nonspecific predictors of 8-week improvement in functional limitations (mRDQ), pain bothersomeness, and depressive symptoms (PHQ-8); effects with P < 0.05 but not statistically significant after Bonferroni correction (X) and statistically significant after Bonferroni correction (B).

Moderators Nonspecific Predictors
CBT – UC MBSR - UC CBT - MBSR
Baseline characteristic mRDQ Pain Bothersomeness PHQ-8 mRDQ Pain Bothersomeness PHQ-8 mRDQ Pain Bothersomeness PHQ-8 mRDQ Pain Bothersomeness PHQ-8
Age X
Gender (female vs male) X X
Education (bachelor’s degree vs less education) ● X
Depressive symptoms, moderate-severe (PHQ-8 ≥10) ● X ● X
Depressive symptoms, mild or more severe (PHQ-8 ≥5) ●X ● X ● X
Pain bothersomeness
Functional limitations (mRDQ)
Widespread pain ● X
Expected pain improvement
Expected program helpfulness
Anxiety (GAD-2) B
SOPA Disability
SOPA Harm X
SOPA Control X X B
SOPA Emotion
Pain self-efficacy (PSEQ) X X
Pain catastrophizing (PCS) X
Pain acceptance (CPAQ-8)
FFMQ-SF OB
FFMQ-SF AA X
FFMQ-SF NR
FFMQ-SF NJ B X X
Opioid use, past wk (vs no use)

AA, Acting with Awareness; CBT, cognitive-behavioral therapy; CPAQ-8, Chronic Pain Acceptance Questionnaire-8; FFMQ-SF, Five Facet Mindfulness Questionnaire-short form; GAD, Generalized Anxiety Disorder; MBSR, Mindfulness-Based Stress Reduction; NJ, Nonjudging; NR, Nonreactivity; OB, Observing; PCS, Pain Catastrophizing Scale; PHQ, Patient Health Questionnaire; PSEQ, Pain Self-Efficacy Questionnaire; mRDQ, modified Roland Disability Questionnaire; SOPA, Survey of Pain Attitudes; UC, Usual Care

● Hypothesized moderator or nonspecific predictor

X Effect with P < 0.05

B Effect that is statistically significant after Bonferroni correction.